|
|
Effect of Zhike Pingchuan Decoction on children with bronchial asthma and its influence on sub-group of T lymphocyte and serum of IL-4 and IFN-γ |
LIU Yuan-song |
Maternal and Child Health Hospital in Luojiang District of Quanzhou City,Fujian Province,Quanzhou 362000,China |
|
|
Abstract ObjectiveTo explore the effect of Zhike Pingchuan Decoction on children with bronchial asthma and its influence on sub-group of T lymphocyte and serum of interferon-γ(IFN-γ)and interleukin-4(IL-4).MethodsA total of 82 children definitely diagnosed as bronchial asthma in our hospital from June 2012 to April 2016 were selected as research objects.They were randomly divided into control group(n=40)and observation group(n=42).In the control group, inhalant of Budesonide Formoterol Powder was used,while in the observation group,Zhike Pingchuan Decoction was added on the basis of the control group.The course of treatment was 3 months.The clinical effect in the two groups was compared.ResultsAfter 3-month therapy,frequency of asthma attack per month and frequency of upper respiratory infection (URI)were both less than those before treatment,the time of asthma after treatment was shorter,the IL-4 level was lower and the INF-γ level was higher in comparison with those before treatment,the differences were statistically significant(P<0.05).In the observation group,frequencies of asthma attack per month and URI were less than those in the control group after 3-month therapy,symptom of asthma was shorter,the level of IL-4 was lower and level of INF-γ was higher than those in the control group after therapy,the differences were statistically significant(P<0.05).In the control group,sub-group of T lymphocytes incuding CD3+,CD4+,and CD4+/CD8+was not greatly improved,while in the observation group,these indexes were significantly improved,the differences were statistically significant(P<0.05).The total effective rate in the observation group was 92.86%,much higher than that in the control group(77.50%),the difference was statistically significant(P<0.05).ConclusionApplication of Zhike Pingchuan Decoction is effective in treating bronchial asthma,which can improve the inflammatory response and immune function,and is worthy of promotion.
|
|
|
|
|
[1] |
全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2014,41(2):123-127.
|
[2] |
徐洪洁.穴位敷贴对支气管哮喘免疫系统影响的研究进展[J].世界中西医结合杂志,2015,10(12):1761-1763.
|
[3] |
高志刚,袁永红,詹建华.丁胺醇气雾剂联合硫酸镁对小儿哮喘IL-2、IL-4、IL-5、IFN-γ及T淋巴细胞亚群的影响[J].中国生化药物杂志,2015,8(35):110-112.
|
[4] |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185.
|
[5] |
国家中医药管理局.中医病证诊断疗效标准[M].南京:南京出版社,1994:7.
|
[6] |
冯湘平,赵辉,陆强.支气管哮喘病因和发病机制的研究进展[J].国际呼吸杂志,2013,33(15):1170-1173.
|
[7] |
曹晓倩.中西医结合治疗小儿咳嗽变异性哮喘的效果研究[J].中西医结合研究,2015,7(2):94-96.
|
[8] |
万建.孟鲁司特联合沙美特罗替卡松对儿童支气管哮喘的疗效及肺功能的影响[J].按摩与康复医学,2014,2(10):34-35.
|
[9] |
陈宽塘.孟鲁司特钠联合沙美特罗/氟替卡松治疗咳嗽变异性哮喘的疗效观察[J].吉林医学,2014,35(3):530-532.
|
[10] |
卢惠伦,何海春,游世伦,等.支气管哮喘患者血清炎症因子与肺功能相关性研究[J].临床肺科杂志,2014,19(1):51-53.
|
[11] |
徐友文,李婉红,张亚琼,等.布地奈德对支气管哮喘儿童血CKLF-1、IL-4和IFN-γ水平的影响[J]中华全科医学,2015,13(6):992-995.
|
[12] |
房体静,冉宝兴,严宏彬.中西医结合治疗支气管哮喘的效果及对免疫功能的影响[J].中医药导报,2013,19(9):48-50.
|
[13] |
蔡晓华.匹多莫德对支气管哮喘患儿免疫功能的影响及疗效分析[J].重庆医学,2014,43(12):1508-1511.
|
[14] |
罗华丽,周萍,贾剑锋.加味玉屏风汤联合艾灸治疗小儿咳嗽变异性哮喘[J].中国实验方剂学杂志,2014,20(10):227-229.
|
[15] |
何炜星,张涤.中医药治疗小儿哮喘缓解期概况[J].湖南中医杂志,2013,29(7):142-144.
|
|
|
|